Metachromatic Leukodystrophy Medication

Updated: Aug 21, 2014
  • Author: Alan K Ikeda, MD; Chief Editor: Luis O Rohena, MD, MS, FAAP, FACMG  more...
  • Print
Medication

Medication Summary

Drug therapy is currently not a component of the standard of care for this disease. Provide supportive care for complications. Recombinant human arylsulfatase A (rhARSA) enzyme is available in Europe and has been designated orphan status in the United States.